Inhibition of membrane ruffling and ezrin translocation by gamma linolenic acid

International Journal of Oncology

Volumn 9, Issue 2, 1996, Pages 279-284

  Jiang, W G ^a   Hiscox, S ^a   Puntis, M C A ^a   Bryce, R P ^b   Horrobin, D F ^b   Mansel, R E ^a   Hallett, M B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Scotia Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Ezrin; Gamma linolenic acid; Membrane ruffling; Metastasis; Tyrosine phosphorylation

Indexed keywords

EZRIN; GAMMA LINOLENIC ACID;

ARTICLE; CARCINOMA CELL; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; TRANSPORT KINETICS;

EID: 0030018739     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.2.279     Document Type: Article

References (40)

1. Begin ME, Ells G, Das UN and Horrobin DF: Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst 77: 1053-1062, 1986.
2. Hayashi Y, Fukushima S, Kishimoto S, Kawaguchi T, Numata M, Isoda Y, Hirano J and Nakano M: Anticancer effects of free polyunsaturated fatty acids in an oily lymphographic agent following intrahepatic arterial administration to a rabbit bearing VX-2 tumor. Cancer Res 52: 400-405, 1992.
3. Rose DP, Connolly JM and Liu XH: Effects of linolenic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res 54: 6557-6562, 1994.
4. Horrobin DF: Essential fatty acids, lipid peroxidation, and cancer. In: ω-6 Essential Fatty Acids. Horrobin DF (ed). Wiley-Liss Publications, New York, pp351-378, 1990.
5. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF and Puntis MCA: Inhibition of hepatocyte growth factor/scatter factor induced motility and invasion of human cancer cells by gamma linolenic acid. Br J Cancer 71: 744-752, 1995.
6. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE and Puntis MCA: Regulation of the expression of E-cadherin in human colon cancer cells by gamma linolenic acid. Cancer Res 55: 5043-5048, 1995.
7. Krieg J and Hunter T: Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem 267: 19258-19265, 1992.
8. Jiang WG: Membrane ruffling of cancer cells: a parameter of tumour cell motility and invasion. Eur J Surg Oncol 21: 307-309, 1995.
9. Ridley AJ: Membrane ruffling and signal transduction. Bioessays 16: 321-327, 1994.
10. Frank S, Footer M and Bretscher A: Microinjection of villin into cultured cells induced rapid and long changes in cell morphology but did not inhibit cytokinesis, cell motility, or membrane ruffling. J Cell Biol 111: 2475-2485, 1990.
11. Doyle GM and Mohler JL: Prediction of metastatic potential of aspirated cells from the Dunning R-3327 prostatic adenocarcinoma model. J Urol 147: 756-759, 1992.
12. Mohler JL, Levy F and Sharief Y: Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Cancer Res 51: 6580-6585, 1991.
13. van Larebeke NA, Bracke ME and Mareel MM: Invasive epithelial cells show more fast plasma membrane movements than related or parental non-invasive cells. Cytometry 13: 9-14, 1992.
14. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S: Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443, 1989.
15. Jiang WG, Hallett MB and Puntis MCA: Hepatocyte growth factor/scatter factor, liver regeneration, and cancer metastasis. Br J Surg 80: 1368-1373, 1993.
16. Stoker M and Gherardi E: Regulation of cell movement. Biochim Biophys Acta 1072: 81-102, 1991.
17. Garrigues J, Anderson J, Hellstom KE and Hellstrom I: Antitumor antibody BR96 blocks cell migration and binds to a lysosomal membrane glycoprotein on cell surface microspikes and ruffled membrane. J Cell Biol 125: 129-142, 1994.
18. Dowrick P, Kenworthy P, McCann B and Warn R: Circular ruffle formation and closure lead to macropinocytosis in hepatocyte growth factor/scatter factor treated cells. Eur J Cell Biol 61: 44-53, 1993.
19. Bretscher A and Lynch W: Identification and localization of immunoreactive forms of caldesmon in smooth and non-muscle cells: a comparison with the distribution of tropomyosin and α-actinin. J Cell Biol 100: 1656-1663, 1985.
20. Bretscher A: Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol 108: 921-930, 1989.
21. Burridge K and Connell L: Talin: a cytoskeletal component concentrated in adhesion plaques and other sites of actin-membrane interations. Cell Motil 3: 405-417, 1983.
22. Campos-Gonzalez R, Kanemitsu M and Boynton AL: Epidermal growth factor induces the accumulation of calpactin II on the cell surface during membrane ruffling. Cell Motil Cytoskeleton 15: 34-40, 1990.
23. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, et al: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75: 826, 1993.
24. Turunen O, Wahlstrom T and Vaheri A: Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol 126: 1445-1453, 1994.
25. Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S and Tsukita S: A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J Cell Sci 103: 131-143, 1992.
26. 2+ and cyclic AMP of the growth factor-induced ruffling membrane formation and stimulation of fluid-phase endocytosis and exocytosis. Exp Cell Res 181: 454-462, 1989.
27. Albrecht-Buehler G: The phagokinetic tracks of 3T3 cells. Cell 11: 395-404, 1977.
28. Rosen E, Meromsky L, Setter E, Vinter DW and Goldberg ID: Smooth muscle-derived factor stimulates mobility of human tumor cells. Invasion Metastasis 10: 49-64, 1990.
29. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
30. Singharao SK, Neal SW and Newman GR: Corpora amulacea could be an indicator of neurodegeneration. Neuropathol Appl Neurobiol 19: 269-276, 1993.
31. Jiang WG, Hiscox S, Singhrao SK, Nakamura T, Puntis MCA and Hallett MB: Inhibitioin of HGF/SF induced membrane ruffling and motility by transient elevation of cytosolic free calcium. Exp Cell Res 220: 424-433, 1995.
32. Berryman M, Franck Z and Bretscher A: Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 105: 1025-1043, 1993.
33. Tsukita S, Oishi K, Sato N, Sagar J, Kawai A and Tsukita S: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391-401, 1994.
34. Schwartz-Albiez R, Merling A, Spring H, Moller P and Koretz K: Differential expression of the microspike-associated protein moesin in human tissues. Eur J Cell Biol 67: 189-198, 1995.
35. Fazioli F, Wong WT, Ullrich SJ, Sakaguchi K, Appella E and Di Fiore PP: The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. Oncogene 8: 1335-1345, 1993.
36. Franck Z, Gary R and Bretscher A: Moesin, like ezrin, colocalizes with actin in the cortical cytoskeleton in cultured cells, but its expression is more variable. J Cell Sci 105: 219-231, 1993.
37. Tsukita S, Hieda Y and Tsuchida S: A new 82-kD barbed end capping protein (radixin) localized in the cell-to-cell adherence junction-purification-and-characterization. J Cell Biol 108: 2369-2382, 1989.
38. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, Plebani M, Gespach C and Comoglio PM: Overexpression and amplification of the MET-HGF receptor gene during the progression of colorectal cancer. Clin Cancer Res 1: 147-154, 1995.
39. Taniguchi T, Toi M, Inada K, Imazawa T, Yamamoto Y and Tominaga T: Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1: 1031-1034, 1995.
40. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T and Shin S: Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 54: 1630-1633, 1994.